← Leaderboards
David T Scadden
Massachusetts General Hospital
$62,181,067
Attributed
$72,227,251
Total exposure
42
Grants
29
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.5M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$108,365,496 · 45
By mechanism
P01$30,683,553 · 13
R01$27,936,483 · 9
U19$17,478,649 · 6
U54$13,193,181 · 6
U01$10,351,528 · 2
R24$3,025,182 · 1
Top collaborators
- Carla F. Kim7 shared
- David J Mooney7 shared
- David A Weitz7 shared
- Raghu Kalluri6 shared
- Peter V Kharchenko4 shared
- Charles P Lin4 shared
- Robert M Westervelt4 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Henry M Kronenberg$26,229,120
- Harald W. Jueppner$19,159,604
- Thomas J Gardella$10,202,128
- Marc Nathan Wein$4,989,017
- Joy Y Wu$5,692,120
Others in their field
Top investigators on “Hematopoietic Stem Cells”
- Mary M Horowitz · Medical College Of Wisconsin$222,127,419
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$80,540,126
- David A Williams · Indiana Univ-Purdue Univ At Indianapolis$36,503,708
- Irving Lerner Weissman · Stanford University$36,281,548
- Bruce R. Blazar · University Of Minnesota$33,175,355
- Marcel R M Van Den Brink · Sloan-Kettering Institute For Cancer Res$31,152,075
Research focus
Hematopoietic Stem CellsStem CellsCellsBaseIn VivoBone MarrowMolecularHematopoieticHematopoiesisMouse ModelGeneticCell TypeAnimalsProgenitorTransplantationBloodHeterogeneityTissuesProductionStressTechnologyBehaviorResearch PersonnelAffect
Grant awards (193)
Functional consequences of stem and progenitor cell heterogeneity$2,482,031
P01 · FY2025 · HL · contact PI
In vivo cell engineering using a bone marrow organoid$673,805
P01 · FY2025 · HL · contact PI
Project 2 - Cell of origin contributions and vulnerabilities in clonal hematopoiesis$488,196
P01 · FY2025 · HL · contact PI
PROJECT 1: Modulating blood cell heterogeneity to reduce cardiovascular inflammation$355,479
P01 · FY2025 · HL · contact PI
Administrative Core$24,666
P01 · FY2025 · HL · contact PI
Functional consequences of stem and progenitor cell heterogeneity$2,475,971
P01 · FY2024 · HL · contact PI
Enhancing regeneration of stem cell-derived HIV-specific immune effectors$515,827
U19 · FY2024 · HL · contact PI
Project 2 - Cell of origin contributions and vulnerabilities in clonal hematopoiesis$485,631
P01 · FY2024 · HL · contact PI
Administrative Core$24,523
P01 · FY2024 · HL · contact PI
Functional consequences of stem and progenitor cell heterogeneity$2,611,725
P01 · FY2023 · HL · contact PI
Enhancing regeneration of stem cell-derived HIV-specific immune effectors$588,701
U19 · FY2023 · HL · contact PI
Project 2 - Cell of origin contributions and vulnerabilities in clonal hematopoiesis$509,925
P01 · FY2023 · HL · contact PI
Project 1: Implications of blood cell heterogeneity for CV disease$392,801
P01 · FY2023 · HL · contact PI
Administrative Core$25,825
P01 · FY2023 · HL · contact PI
Enhancing regeneration of stem cell-derived HIV-specific immune effectors$552,734
U19 · FY2022 · HL · contact PI
Project 1: Implications of blood cell heterogeneity for CV disease$392,801
P01 · FY2022 · HL · contact PI
Functional consequences of stem and progenitor cell heterogeneity$2,402,543
P01 · FY2021 · HL · contact PI
Enhancing regeneration of stem cell-derived HIV-specific immune effectors$499,737
U19 · FY2021 · HL · contact PI
Clonal tracking and molecular characterization of hematopoiesis under stress$417,846
P01 · FY2021 · HL · contact PI
Project 1: Implications of blood cell heterogeneity for CV disease$392,800
P01 · FY2021 · HL · contact PI
Administrative Core$288,050
P01 · FY2021 · HL · contact PI
Clonal tracking and molecular characterization of hematopoiesis under stress$50,400
P01 · FY2021 · HL · contact PI
Functional consequences of stem and progenitor cell heterogeneity$50,400
P01 · FY2021 · HL · contact PI
Functional consequences of stem and progenitor cell heterogeneity$2,402,543
P01 · FY2020 · HL · contact PI
Enhancing regeneration of stem cell-derived HIV-specific immune effectors$514,184
U19 · FY2020 · AI · contact PI
Clonal tracking and molecular characterization of hematopoiesis under stress$417,846
P01 · FY2020 · HL · contact PI
Project 1: Implications of blood cell heterogeneity for CV disease$392,800
P01 · FY2020 · HL · contact PI
Administrative Core$288,050
P01 · FY2020 · HL · contact PI
Project 1: Clonal Dynamics Guiding Curative Therapies for Acute Myeloid Leukemia$126,492
U54 · FY2020 · CA · contact PI
Functional consequences of stem and progenitor cell heterogeneity$50,400
P01 · FY2020 · HL · contact PI
Functional consequences of stem and progenitor cell heterogeneity$2,402,543
P01 · FY2019 · HL · contact PI
A defend and destroy approach to curing HIV$2,294,182
U19 · FY2019 · HL · contact PI
Engineered bone marrow niche to reconstitute T cell immunity$2,076,253
U54 · FY2019 · CA · contact PI
Improving Stem Cell Transplant Safety and Efficacy to Cure HIV-1 Infection$725,381
U19 · FY2019 · HL · contact PI
MSC Encapsulation with Thin Gel Coating$663,590
R01 · FY2019 · EB
Deconvoluting the hematopoietic niche under stress$514,508
R01 · FY2019 · DK · contact PI
Project 1: Clonal Dynamics Guiding Curative Therapies for Acute Myeloid Leukemia$456,560
U54 · FY2019 · CA · contact PI
Clonal tracking and molecular characterization of hematopoiesis under stress$417,846
P01 · FY2019 · HL · contact PI
Project 1: Implications of blood cell heterogeneity for CV disease$392,801
P01 · FY2019 · HL · contact PI
Administrative Core$288,050
P01 · FY2019 · HL · contact PI
CORE A: Administrative and Biostatisitcs Core$245,295
U19 · FY2019 · HL · contact PI
Functional consequences of stem and progenitor cell heterogeneity$2,405,436
P01 · FY2018 · HL · contact PI
A defend and destroy approach to curing HIV$2,294,182
U19 · FY2018 · HL · contact PI
Cell and Molecular Dynamics of Hematopoiesis In Vivo$739,629
R24 · FY2018 · DK · contact PI
MSC Encapsulation with Thin Gel Coating$665,836
R01 · FY2018 · EB
(PQC2) Localization as a determinant of cancer dormancy$525,066
R01 · FY2018 · CA
Deconvoluting the hematopoietic niche under stress$514,508
R01 · FY2018 · DK · contact PI
Improving Stem Cell Transplant Safety and Efficacy to Cure HIV-1 Infection$422,500
U19 · FY2018 · HL · contact PI
Clonal tracking and molecular characterization of hematopoiesis under stress$409,875
P01 · FY2018 · HL · contact PI
Project 1: Clonal Dynamics Guiding Curative Therapies for Acute Myeloid Leukemia$366,060
U54 · FY2018 · CA · contact PI
Administrative Core$282,535
P01 · FY2018 · HL · contact PI
CORE A: Administrative and Biostatisitcs Core$160,620
U19 · FY2018 · HL · contact PI
A defend and destroy approach to curing HIV$50,700
U19 · FY2018 · HL · contact PI
Functional consequences of stem and progenitor cell heterogeneity$2,481,366
P01 · FY2017 · HL · contact PI
A defend and destroy approach to curing HIV$2,285,732
U19 · FY2017 · HL · contact PI
Cell and Molecular Dynamics of Hematopoiesis In Vivo$761,851
R24 · FY2017 · DK · contact PI
MSC Encapsulation with Thin Gel Coating$685,266
R01 · FY2017 · EB
(PQC2) Localization as a determinant of cancer dormancy$553,740
R01 · FY2017 · CA
Project 1: Clonal Dynamics Guiding Curative Therapies for Acute Myeloid Leukemia$532,795
U54 · FY2017 · CA · contact PI
Deconvoluting the hematopoietic niche under stress$514,508
R01 · FY2017 · DK · contact PI
Improving Stem Cell Transplant Safety and Efficacy to Cure HIV-1 Infection$422,500
U19 · FY2017 · HL · contact PI
Clonal tracking and molecular characterization of hematopoiesis under stress$398,812
P01 · FY2017 · HL · contact PI
Administrative Core$289,305
P01 · FY2017 · HL · contact PI
CORE A: Administrative and Biostatisitcs Core$152,170
U19 · FY2017 · HL · contact PI
A defend and destroy approach to curing HIV$2,285,732
U19 · FY2016 · HL · contact PI
Cell and Molecular Dynamics of Hematopoiesis In Vivo$761,851
R24 · FY2016 · DK · contact PI
Deconvoluting the hematopoietic niche under stress$558,932
R01 · FY2016 · DK · contact PI
Project 1: Clonal Dynamics Guiding Curative Therapies for Acute Myeloid Leukemia$543,982
U54 · FY2016 · CA · contact PI
(PQC2) Localization as a determinant of cancer dormancy$527,391
R01 · FY2016 · CA
Improving Stem Cell Transplant Safety and Efficacy to Cure HIV-1 Infection$422,500
U19 · FY2016 · HL · contact PI
In vivo tracking of the hematopoietic stem cell clonal dynamics using a novel multi-fluorescent transgenic mouse model$239,540
R21 · FY2016 · HL · contact PI
CORE A: Administrative and Biostatisitcs Core$152,170
U19 · FY2016 · HL · contact PI
A defend and destroy approach to curing HIV$2,327,582
U19 · FY2015 · HL · contact PI
Microenvironmental control of progenitors in organ dysfunction and repair$1,212,867
U01 · FY2015 · HL · contact PI
Stromal Regulation of Bone Metastasis$1,129,443
U54 · FY2015 · CA
Cell and Molecular Dynamics of Hematopoiesis In Vivo$761,851
R24 · FY2015 · DK · contact PI
(PQC2) Localization as a determinant of cancer dormancy$547,017
R01 · FY2015 · CA
Project 1: Clonal Dynamics Guiding Curative Therapies for Acute Myeloid Leukemia$510,545
U54 · FY2015 · CA · contact PI
Mechanisms of Hematopoiesis in AIDS$478,831
R01 · FY2015 · HL · contact PI
Improving Stem Cell Transplant Safety and Efficacy to Cure HIV-1 Infection$422,500
U19 · FY2015 · HL · contact PI
Bone Microenvironment Contributions to Metastatic Disease$286,217
U54 · FY2015 · CA · contact PI
In vivo tracking of the hematopoietic stem cell clonal dynamics using a novel multi-fluorescent transgenic mouse model$199,740
R21 · FY2015 · HL · contact PI
CORE A: Administrative and Biostatisitcs Core$143,720
U19 · FY2015 · HL · contact PI
Microenvironmental control of progenitors in organ dysfunction and repair$1,206,710
U01 · FY2014 · HL · contact PI
Stromal Regulation of Bone Metastasis$975,515
U54 · FY2014 · CA
Building the Hematopoietic Stem Cell Niche$779,887
R01 · FY2014 · EB
Mechanisms of Hematopoiesis in AIDS$476,433
R01 · FY2014 · HL · contact PI
Bone Microenvironment Contributions to Metastatic Disease$449,984
U54 · FY2014 · CA · contact PI
Microenvironmental control of progenitors in organ dysfunction and repair$1,172,232
U01 · FY2013 · HL · contact PI
Stromal Regulation of Bone Metastasis$901,885
U54 · FY2013 · CA
Building the Hematopoietic Stem Cell Niche$768,726
R01 · FY2013 · EB
Mechanisms of Hematopoiesis in AIDS$462,865
R01 · FY2013 · HL · contact PI
Bone Microenvironment Contributions to Metastatic Disease$292,577
U54 · FY2013 · CA · contact PI
Microenvironmental control of progenitors in organ dysfunction and repair$1,231,337
U01 · FY2012 · HL · contact PI
Stromal Regulation of Bone Metastasis$866,890
U54 · FY2012 · CA
Building the Hematopoietic Stem Cell Niche$755,177
R01 · FY2012 · EB
Stem Cell Engagement of the Niche$574,241
R01 · FY2012 · HL · contact PI
Mechanisms of Hematopoiesis in AIDS$486,670
R01 · FY2012 · HL · contact PI
Harvard Stem Cell Institute Training Program for Pre- and Post-Doctoral Fellows$304,339
T32 · FY2012 · HL · contact PI
Mechanisms of Hematopoiesis in AIDS$296,404
R01 · FY2012 · HL · contact PI
Bone Microenvironment Contributions to Metastatic Disease$274,218
U54 · FY2012 · CA · contact PI
Bone Microenvironment Contributions to Metastatic Disease$273,996
U54 · FY2012 · CA · contact PI
Dynamic interactions between stem cell and their niche$199,084
R01 · FY2012 · DK · contact PI
Stromal Regulation of Bone Metastasis$35,566
U54 · FY2012 · CA
Microenvironmental control of progenitors in organ dysfunction and repair$1,231,337
U01 · FY2011 · HL · contact PI
Stromal Regulation of Bone Metastasis$925,878
U54 · FY2011 · CA
Building the Hematopoietic Stem Cell Niche$766,124
R01 · FY2011 · EB
Stem Cell Engagement of the Niche$580,922
R01 · FY2011 · HL · contact PI
Mechanisms of Hematopoiesis in AIDS$490,215
R01 · FY2011 · HL · contact PI
Harvard Stem Cell Institute Training Program for Pre- and Post-Doctoral Fellows$227,146
T32 · FY2011 · HL · contact PI
Microenvironmental control of progenitors in organ dysfunction and repair$1,215,274
U01 · FY2010 · HL · contact PI
Center for Regenerative Medicine (CRM) Support for New Faculty Member$761,184
P30 · FY2010 · HL · contact PI
Stem Cell Engagement of the Niche$593,133
R01 · FY2010 · HL · contact PI
Targeted Manipulation of Stem Cells for AIDS Therapy$544,597
R01 · FY2010 · HL · contact PI
Mechanisms of Hematopoiesis in AIDS$520,702
R01 · FY2010 · HL · contact PI
Harvard Stem Cell Institute Training Program for Pre- and Post-Doctoral Fellows$421,417
T32 · FY2010 · HL · contact PI
Dynamic interactions between stem cells and their niche.$308,969
R01 · FY2010 · DK · contact PI
ENHANCEMENT OF STEM CELL ENGRAFTMENT AND IMMUNE RECOVERY FOLLOWING HEMATOPOIETIC$118,904
P01 · FY2010 · CA · contact PI
Microenvironmental control of progenitors in organ dysfunction and repair$1,275,815
U01 · FY2009 · HL · contact PI
Center for Regenerative Medicine (CRM) Support for New Faculty Member$715,076
P30 · FY2009 · HL · contact PI
Stem Cell Engagement of the Niche$622,525
R01 · FY2009 · HL · contact PI
Targeted Manipulation of Stem Cells for AIDS Therapy$521,772
R01 · FY2009 · HL · contact PI
Mechanisms of Hematopoiesis in AIDS$494,136
R01 · FY2009 · HL · contact PI
Harvard Stem Cell Institute Training Program for Pre- and Post-Doctoral Fellows$417,931
T32 · FY2009 · HL · contact PI
Dynamic interactions between stem cells and their niche.$316,321
R01 · FY2009 · DK · contact PI
ENHANCEMENT OF STEM CELL ENGRAFTMENT AND IMMUNE RECOVERY FOLLOWING HEMATOPOIETIC$117,251
P01 · FY2009 · CA · contact PI
Mesenchyme Organizers of Organ Development, Maintenance and Repair$44,000
R03 · FY2009 · HL · contact PI
Targeted Manipulation of Stem Cells for AIDS Therapy$500,811
R01 · FY2008 · HL · contact PI
Mechanisms of Hematopoiesis in AIDS$478,992
R01 · FY2008 · HL · contact PI
Harvard Stem Cell Institute Training Program for Pre- and Post-Doctoral Fellows$355,505
T32 · FY2008 · HL · contact PI
Dynamic interactions between stem cells and their niche.$319,496
R01 · FY2008 · DK · contact PI
ENHANCEMENT OF STEM CELL ENGRAFTMENT AND IMMUNE RECOVERY FOLLOWING HEMATOPOIETIC$101,632
P01 · FY2008 · CA · contact PI
Targeted Manipulation of Stem Cells for AIDS Therapy$481,506
R01 · FY2007 · HL · contact PI
Mechanisms of Hematopoiesis in AIDS$465,555
R01 · FY2007 · HL · contact PI
Dynamic interactions between stem cells and their niche.$328,986
R01 · FY2007 · DK · contact PI
ENHANCEMENT OF STEM CELL ENGRAFTMENT AND IMMUNE RECOVERY FOLLOWING HEMATOPOIETIC$115,911
P01 · FY2007 · CA · contact PI
Targeted Manipulation of Stem Cells for AIDS Therapy$459,988
R01 · FY2006 · HL · contact PI
Mechanisms of Hematopoiesis in AIDS$446,395
R01 · FY2006 · HL · contact PI
ENHANCEMENT OF STEM CELL ENGRAFTMENT AND IMMUNE RECOVERY FOLLOWING HEMATOPOIETIC$59,030
P01 · FY2006 · CA · contact PI
Specialized Center for Cell Based Therapy$2,168,325
U54 · FY2005 · HL
Mechanisms of Hematopoiesis in AIDS$432,500
R01 · FY2005 · HL
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY$408,290
R01 · FY2005 · HL
Oral immune responses in human and simian herpesvirus infection$223,694
P01 · FY2005 · DE
Mechanisms of Hematopoiesis in AIDS$432,500
R01 · FY2004 · HL
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY$408,290
R01 · FY2004 · HL
Functional Isolation of Human Hematopoietic Stem Cells$341,374
R01 · FY2004 · DK
Functional Isolation of Human Hematopoietic Stem Cells$250,558
R01 · FY2004 · DK
BOSTON AIDS MALIGNANCY CONSORTIUM$225,467
U01 · FY2004 · CA
Oral immune responses in human and simian herpesvirus infection$217,179
P01 · FY2004 · DE
Mechanisms of Hematopoiesis in AIDS$432,500
R01 · FY2003 · HL
BOSTON AIDS MALIGNANCY CONSORTIUM$418,282
U01 · FY2003 · CA
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY$408,290
R01 · FY2003 · HL
Functional Isolation of Human Hematopoietic Stem Cells$341,374
R01 · FY2003 · DK
Functional Isolation of Human Hematopoietic Stem Cells$245,168
R01 · FY2003 · DK
Oral immune responses in human and simian herpesvirus infection$209,209
P01 · FY2003 · DE
Mechanisms of Hematopoiesis in AIDS$432,500
R01 · FY2002 · HL
BOSTON AIDS MALIGNANCY CONSORTIUM$408,452
U01 · FY2002 · CA
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY$408,290
R01 · FY2002 · HL
Functional Isolation of Human Hematopoietic Stem Cells$341,374
R01 · FY2002 · DK
T CELL NEOGENESIS AFTER STEM CELL TRANSPLANTATION$247,466
P01 · FY2002 · AI
Hematopoietic cell tracking$241,412
P50 · FY2002 · CA
Hematopoietic cell tracking$241,412
P50 · FY2002 · CA
Oral immune responses in human and simian herpesvirus infection$209,209
P01 · FY2002 · DE
COL-3 in HIV associated Kaposi's Sarcoma$200,768
M01 · FY2002 · RR
COL-3 in HIV associated Kaposi's Sarcoma$200,768
M01 · FY2002 · RR
Functional Isolation of Human Hematopoietic Stem Cells$187,679
R01 · FY2002 · DK
KAPOSI'S SARCOMA HERPESVIRUS AS TARGET FOR IMMUNOTHERAPY IN MULTIPLE MYELOMA$109,507
P01 · FY2002 · CA
Core--Developmental$0
P30 · FY2002 · AI
Core--Developmental$0
P30 · FY2002 · AI
Mechanisms of Hematopoiesis in AIDS$432,500
R01 · FY2001 · HL
TARGETED MANIPULATION OF STEM CELLS FOR AIDS THERAPY$408,290
R01 · FY2001 · HL
BOSTON AIDS MALIGNANCY CONSORTIUM$397,171
U01 · FY2001 · CA
BOSTON AIDS ONCOLOGY TRAINING PROGRAM$346,032
K12 · FY2001 · CA
Functional Isolation of Human Hematopoietic Stem Cells$337,842
R01 · FY2001 · DK
T CELL NEOGENESIS AFTER STEM CELL TRANSPLANTATION$247,466
P01 · FY2001 · AI
Hematopoietic cell tracking$241,412
P50 · FY2001 · CA
Oral immune responses in human and simian herpesvirus infection$209,209
P01 · FY2001 · DE
COL-3 in HIV associated Kaposi's Sarcoma$200,768
M01 · FY2001 · RR
Functional Isolation of Human Hematopoietic Stem Cells$182,212
R01 · FY2001 · DK
KAPOSI'S SARCOMA HERPESVIRUS AS TARGET FOR IMMUNOTHERAPY IN MULTIPLE MYELOMA$109,507
P01 · FY2001 · CA
Hematopoietic cell tracking$0
P50 · FY2001 · CA
COL-3 in HIV associated Kaposi's Sarcoma$0
M01 · FY2001 · RR
Core--Developmental$0
P30 · FY2001 · AI
MECHANISMS OF HEMATOPOIESIS IN AIDS$412,705
R01 · FY2000 · HL
BOSTON AIDS MALIGNANCY CONSORTIUM$356,584
U01 · FY2000 · CA
BOSTON AIDS ONCOLOGY TRAINING PROGRAM$338,470
K12 · FY2000 · CA
IMMUNOBIOLOGY OF HHV8 IN KAPOSIS SARCOMA$302,422
R01 · FY2000 · CA
KAPOSI'S SARCOMA HERPESVIRUS AS TARGET FOR IMMUNOTHERAPY IN MULTIPLE MYELOMA$275,287
P01 · FY2000 · CA
T CELL NEOGENESIS AFTER STEM CELL TRANSPLANTATION$247,466
P01 · FY2000 · AI
Core--Developmental$0
P30 · FY2000 · AI
Hematopoietic cell tracking$0
P50 · FY2000 · CA
COL-3 in HIV associated Kaposi's Sarcoma$0
M01 · FY2000 · RR
COL-3 in HIV associated Kaposi's Sarcoma$0
M01 · FY2000 · RR